A significant amount of money is spent on medicines in the NHS – around £17.4 billion per year, and they are the most common treatment used. Jas Khambh, national pharmacy adviser for RightCare at NHS England, explains how it can support the Medicines Value Programme. The growth in medicines spend is increasing year on year, […]
Note: Some sections of this case study refer to clinical commissioning groups (CCGs). On 1st July 2022, integrated care systems (ICSs) took over statutory commissioning responsibilities in England, and CCGs were closed down. You can learn more about integrated care systems (ICSs) here. Case study summary A group of pharmacists from Bury Clinical Commissioning Group […]
Tens of thousands of patients requiring chemotherapy could receive treatment closer to home under new plans set out by the health service today. Substantial savings are also expected to be reinvested in patient care over the next few years thanks to an NHS England programme led by specialist pharmacists to reduce variation in drug doses. […]
Definition of a biosimilar medicine A biosimilar medicine is a biological medicine which has been shown not to have any clinically meaningful differences from the originator medicine in terms of quality, safety and efficacy. Where NICE has already recommended the originator biological medicine, the same guidance will normally apply to a biosimilar of that originator. In an era of […]
The evidence is clear that if we want to improve outcomes for local populations, we need to embrace leadership at all levels of an integrated care system (ICS). NHS England’s guidance on effective clinical and care professional leadership (CCPL) supports this and sets out five core principles describing what ‘good’ looks like. Since its publication […]
“Our vision is that the power of genomics in predicting, preventing and diagnosing disease, and targeting treatment is accessible to all as part of routine care in the NHS.” This is the first line from the Accelerating Genomic Medicine in the NHS strategy published at the inaugural NHS Genomics Healthcare Summit in late 2022. Just […]
In October 2022, NHS England published Accelerating Genomic Medicine in the NHS, the first NHS genomics strategy. The strategy included a plan to establish ‘NHS Genomic Networks of Excellence’ as part of its commitment to provide a world-leading NHS Genomic Medicine Service (GMS) which provides cutting-edge benefits for patients in the NHS. NHS England is […]
The Chief Pharmaceutical Officer (CPhO) is the head of the pharmacist and pharmacy technician professions in England, a workforce of over 72,000 highly trained, registered professionals in hospitals, community healthcare, general practices and community pharmacies. He is the principal advisor on pharmacy and medicines use in the NHS, which includes supporting the Department of Health and Social […]
Case finding Community pharmacy hypertension case finding Cholesterol search and risk stratification NHS Health Check Optimising treatment Case finding and direct-acting oral anticoagulation (DOACs) to prevent atrial fibrillation (AF) related strokes Cardiac rehabilitation for patients post ACS and diagnosis of heart failure Optimisation of hypertension treatment Optimisation of heart failure treatment through annual reviews Optimising […]
Spirometry in diagnosis of asthma and chronic obstructive pulmonary disease (COPD) Inhaler and medicines optimisation Personalised Asthma Action Plan (PAAP) for all children and young people (CYP) with asthma Download these high impact interventions as a table (PDF). Spirometry in diagnosis of asthma and chronic obstructive pulmonary disease (COPD) Targeted testing in primary care […]